Home
Our news
‘Real world’ data shows 83 percent effectiveness for Bexsero® in infants in first year of UK national meningitis B immunisation programme
GSK announce positive results from the COPD Salford Lung Study published in the NEJM and presented at European Respiratory Congress
NEJM publishes results of GSK’s long-term LABA safety study of Advair® Diskus® in children aged 4-11 years with asthma
Corporate reporting
Join the conversation
Tweets from GSK
-
As the athletes are gearing up, we’re preparing to launch our #WinforMeningitis photos w/@annegeddestweet this month https://t.co/3fvnmIT7C7
15 hours ago
-
Just over two weeks left to apply for the #GSKIMPACTUK Awards 2017, closing 21 Sept #InternationalDayofCharity https://t.co/zJ5BeiNQMN
17 hours ago
Explore our products
We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products.
